Bortezomib in KRAS-Mutant Non-Small Cell Lung Cancer in Never Smokers or Those With KRAS G12D
Clinical trial NCT01833143 · COMPLETED
Trial details
- NCT number
- NCT01833143
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-11
- Primary completion
- 2019-08-28
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.